Signal Podcast
A podcast that explores how your medicines get made. Subscribe to Signal on iTunes or Stitcher or Google Play. Get an alert when each new episode drops by clicking here.
Most Read
Pharmalittle: FDA OKs new type of diabetes drug from Lilly; Early-stage biotechs are juicy targets for M&A surge
Seagen CEO resigns after arrest on domestic assault charges
One million reasons to reimagine end-of-life care
A ‘city on fire’: How Miami shaped a disputed diagnosis used to justify deaths in police custody
Puzzling pediatric hepatitis cases echo an earlier mysterious illness
When biotech acquisitions spike, early-stage startups are prime targets, analysis shows
FDA approves Lilly diabetes drug that analysts expect to be a big seller
All Coverage
advertisement
